Carlos Doti
Vice President, US Cell Therapy, US Oncology Business Unit
Responsibilities
Carlos Doti is Vice President, US Cell Therapy at AstraZeneca. In this role, he leads the US Oncology Cell Therapy Franchise, bringing together commercial marketing, sales, and medical functions into a single end-to-end team to support high-impact and seamless cell therapy launches in the US.
Prior Experience
Prior to his current role, Carlos served as Vice President and Head of Medical Affairs for the US Oncology Business Unit, where he was responsible for leading the development and delivery of medical strategy across AstraZeneca’s US oncology portfolio. Before that, he held multiple Commercial and Medical Affairs leadership positions within the Oncology Business Unit across international markets and at the global level, including Global Medical Franchise Head of Hematology, Hematology Franchise Director (International Region) and Oncology Business Unit Director.
Education
- MD, Hematology, University of Buenos Aires
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.